Professor Wendy Atkin
Professor Wendy Atkin moved to the St Mary’s Hospital Campus at Imperial College in 2008 to establish the Cancer Screening and Prevention Research Group (CSPRG). She heads the CSPRG, an internationally-renowned, multidisciplinary group undertaking research focusing primarily on bowel cancer, which includes looking at the patterns of bowel cancer in the general population, screening, early diagnosis, how bowel cancer develops and how to monitor people who are at higher risk. The ultimate aim of this research is to reduce the numbers of people diagnosed with, and dying from bowel cancer. She is also the Information Governance Lead for the CSPRG, and so has responsibilities for ensuring that information held by the CSPRG for the purposes of its research is used appropriately and that the necessary safeguards are in place.
- Fellowship of The Academy of Medical Sciences, The Academy of Medical Sciences, 2015;
- Officer of the Most Excellent Order of the British Empire (OBE) – awarded for services to Bowel Cancer Prevention, 2013;
- Bengt Ihre Medal, The Swedish Society of Medicine, 2012;
- BSG President’s Medal (2011), British Society of Gastroenterologists, 2011;
Dr Amanda Cross
Dr Cross is a Reader in Cancer Epidemiology at the St Mary’s Hospital Campus of the Faculty of Medicine within Imperial College London. In 2015, she became the Assistant Head of the Cancer Screening and Prevention Research Group (CSPRG). She completed her PhD at Cambridge University and then spent 11 years within the Division of Cancer Epidemiology and Genetics (DCEG) at the National Cancer Institute (NCI), National Institutes of Health (NIH) in the United States. During her time as an investigator at NCI, she was also a mentor for the Yale University– NCI Partnership Training Program and held the position of Assistant Professor Adjunct within the Division of Chronic Disease Epidemiology at Yale University, New Haven, Connecticut. In the United States, Dr Cross was one of the Principal Investigators of the Polyp Prevention Trial and the CONCeRN study, both colonoscopy screening studies, and she was also one of the Principal Investigators of the U.S. Polyp Pooling Project.
- NIH Fellows Award for Research Excellence;
- DCEG Fellowship Achievement Award for Outstanding Accomplishments;
- DCEG Award for Outstanding Research Paper;
- NCI Mentor of Merit Award;
- NIH Merit Award for Leadership of an Innovative Multidisciplinary Research Program.
Elizabeth (Liz) is an experienced research support officer with a nursing and clinical trials background.
She provides support to both Professor Atkin and the whole team to ensure that all research projects run smoothly and professionally.
Kate is an experienced medical statistician who has worked with the CSPRG for more than eight years, in particular on the UKFSST, SIGGAR and IA studies. As our senior statistician, Kate leads on the statistical analysis on many of our trials, and provides significant input to the design of future studies. Her role also involves preparing data for analysis, performing statistical analyses and preparing the results for publication, as well as contributing to the writing up of manuscripts and the management of the group’s studies and trials.
Dr Paula Kirby
Paula joined CSPRG in 2015 and is responsible for the operational and financial management of all projects. Paula has several years of clinical trial management experience (academic and pharmaceutical industry), and is an experienced Project Manager (PMP qualified). Additional responsibilities include drafting grant applications; administering new and existing grants; dealing with ethics, R&D, clinical governance and quality assurance regulations; liaising with legal teams to arrange sponsorship and establish contracts; convening and co-ordinating monitoring committees, and recruiting trial staff as required.
Eilidh initially joined the CSPRG in 2007 as a data clerk to work on the UK Flexible Sigmoidoscopy Screening Trial. She was responsible for retrieving and interpreting the pathology and clinical reports for each of the participants in the UKFSST. Eilidh has since progressed within the group and is currently the clinical trial manager for the FIT for Follow-Up Study.
After 15 years working in laboratories on the molecular genetics of bowel cancer including occasional scientific projects for Professor Wendy Atkin, Kevin took on his current role within CSPRG. He has been involved in administration, data collection, coding and data cleaning for several studies, liaising with individuals from various disciplines in dozens of hospitals. Projects have included UKFSST, SIGGAR, the Intermediate Adenoma study, SOCCER and currently the FIT for Follow-Up study.
Bhavita joined the CSPRG team with previous experience in Biomedical Science and has worked in private and NHS pathology laboratories. Bhavita is responsible for the collection, entry, coding and cleaning of clinical trial data and has worked on a number of CSPRG projects including SOCCER, FIT for Follow-Up and more recently the FIT for Diagnosis study. Bhavita is currently collecting data across various hospital sites for both the development and pilot phases of the FIT for Diagnosis study. Bhavita hopes to build on her clinical research skills and responsibilities by providing assistance with the development of study documentation for the Fit for Diagnosis study.
Before joining the CSPRG in 2014, Iain worked as a data analyst in telecommunications and as a C++ developer for scientific applications. He now manages the study databases, collects clinical data, drafts IG policy and provides day-to-day technical support for the group. This work includes systems administration and security; liaising with NHS hospitals and other providers to gather clinical data; designing patient management systems and other data-processing applications; and maintaining compliance with CSPRG Information Governance policies. It is also Iain’s role to understand the requirements of the CSPRG statisticians and provide them with the data they need. He is generally interested in anything that can improve methods of extracting or normalising clinical data and in the legal and ethical aspects of clinical data collection.